We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-8.37%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.28B
AUM Growth
-$1.41B
Cap. Flow
-$1.19B
Cap. Flow %
-22.61%
Top 10 Hldgs %
53.54%
Holding
466
New
23
Increased
24
Reduced
24
Closed
360

Top Buys

Rank Stock Value
1
NAMS icon
NewAmsterdam Pharma
NAMS
+$72.5M
2
LEGN icon
Legend Biotech
LEGN
+$64.3M
3
OSCR icon
Oscar Health
OSCR
+$64.1M
4
DVAX
Dynavax Technologies
DVAX
+$62.6M
5
INDV icon
Indivior Pharmaceuticals
INDV
+$39M

Top Sells

Rank Stock Value
1
NUVL
Nuvalent
NUVL
+$187M
2
KURA icon
Kura Oncology
KURA
+$106M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$66.5M
4
SGRY icon
Surgery Partners
SGRY
+$57.4M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$56.2M

Sector Composition

Rank Sector Weight
1 Healthcare 87.97%
2 Industrials 0.23%
3 Consumer Staples 0.01%
4 Energy 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAHC icon
326
Phibro Animal Health
PAHC
$1.5B
– –
-15,055
Closed -$339K
PARA
327
DELISTED
Paramount Global Class B
PARA
– –
-62,516
Closed -$664K
PATH icon
328
UiPath
PATH
$6.52B
– –
-13,391
Closed -$171K
PAYC icon
329
Paycom
PAYC
$7.88B
– –
-3,126
Closed -$521K
PEBO icon
330
Peoples Bancorp
PEBO
$1.51B
– –
-25,004
Closed -$752K
PFG icon
331
Principal Financial Group
PFG
$24.3B
– –
-6,268
Closed -$538K
PGNY icon
332
Progyny
PGNY
$2.46B
– –
-47,535
Closed -$797K
PINC
333
DELISTED
Premier
PINC
– –
-78,878
Closed -$1.58M
PLAB icon
334
Photronics
PLAB
$1.65B
– –
-41,813
Closed -$1.04M
PLD icon
335
Prologis
PLD
$136B
– –
-5,618
Closed -$709K
PLMR icon
336
Palomar
PLMR
$3.79B
– –
-5,292
Closed -$501K
PM icon
337
Philip Morris
PM
$309B
– –
-6,082
Closed -$738K
PMT
338
PennyMac Mortgage Investment
PMT
$845M
– –
-53,221
Closed -$759K
PNC icon
339
PNC Financial Services
PNC
$99.1B
– –
-1,559
Closed -$288K
PODD icon
340
Insulet
PODD
$11.8B
– –
-109,600
Closed -$25.5M
POST icon
341
Post Holdings
POST
$4.42B
– –
-4,850
Closed -$561K
PPBI
342
DELISTED
Pacific Premier Bancorp
PPBI
– –
-37,705
Closed -$949K
PPG icon
343
PPG Industries
PPG
$24.9B
– –
-6,216
Closed -$823K
PRCT icon
344
Procept Biorobotics
PRCT
$1.02B
– –
-8,190
Closed -$656K
PRDO icon
345
Perdoceo Education
PRDO
$2.17B
– –
-17,759
Closed -$395K
PRLD icon
346
Prelude Therapeutics
PRLD
$375M
– –
-3,766,120
Closed -$7.8M
PRLB icon
347
Protolabs
PRLB
$1.7B
– –
-16,210
Closed -$476K
PRME icon
348
Prime Medicine
PRME
$547M
– –
-896,960
Closed -$3.47M
PRVA icon
349
Privia Health
PRVA
$3.04B
– –
-79,941
Closed -$1.46M
PSA icon
350
Public Storage
PSA
$61.5B
– –
-856
Closed -$311K
12 13
14
15 16

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q4 2024 Portfolio in Review

As of Q4 2024, Deerfield Management held 466 positions worth $5.28B, down 21% from $6.69B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $1.19B in Q4 2024, closing 360 positions and reducing 24 holdings. Its most notable exit was Kura Oncology, an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 87% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Deerfield Management opened a new position in Legend Biotech worth $50.5M.

  • Deerfield Management's largest Q4 2024 buy was Legend Biotech: 1,551,718 shares worth $50.5M.
  • Deerfield Management added most to NewAmsterdam Pharma in Q4 2024, an estimated $72.5M increase.
  • Deerfield Management's biggest Q4 2024 reduction was Nuvalent, cutting an estimated $187M.
  • Deerfield Management fully exited Kura Oncology in Q4 2024, selling an estimated $106M.
  • Deerfield Management's ten largest holdings make up 54% of its $5.28B portfolio in Q4 2024.
  • Deerfield Management opened 23 new positions and closed 360 in Q4 2024.
  • Deerfield Management's portfolio value fell 21% quarter-over-quarter to $5.28B.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.